Greenlane Holdings, Inc. Form 8-K Summary
Business context and reporting period
Greenlane filed this Current Report on Form 8-K on April 1, 2021, reporting events dated March 31, 2021. The filing concerns Greenlane’s proposed merger with KushCo Holdings, Inc.; it does not report quarterly or annual operating results.
Transaction terms and key financial information
- Greenlane, through two wholly owned merger subsidiaries, entered into an Agreement and Plan of Merger with KushCo.
- KushCo stockholders are expected to receive approximately 0.2546 shares of Greenlane Class A common stock for each KushCo share, subject to adjustment.
- Based on the base exchange ratio, KushCo stockholders are expected to own approximately 49.9% and existing Greenlane stockholders approximately 50.1% of Greenlane’s Class A common stock after closing.
- If Greenlane issues securities before closing for acquisitions or capital raising, the exchange ratio will be adjusted so existing Greenlane stockholders retain between 50.1% and 51.9% of the combined company.
- The filing provides no revenue, profit, cash-flow, margin, debt, cash-balance, liquidity, or other operating metrics for the reporting period.
- Greenlane’s authorized Class A shares would increase from 125 million to 600 million, subject to approval. Authorized Class B shares would increase from 10 million to 30 million, and each Class C share would convert into three Class B shares.
Material changes versus the prior comparable period
The filing does not provide comparative financial statements or operating-period results. The material development is the execution of the proposed KushCo merger agreement and related governance, equity, and voting arrangements.
Governance, equity awards, and management
- After closing, the board is expected to have seven members: four existing Greenlane directors and three KushCo directors.
- Nicholas Kovacevich is expected to become Chief Executive Officer; Aaron LoCascio is expected to serve as President; Adam Schoenfeld is expected to remain Chief Strategy Officer; and William Mote is expected to remain Chief Financial Officer.
- All unvested Greenlane equity awards, other than awards held by non-employee directors, will fully vest immediately before the first merger becomes effective. KushCo restricted stock units will vest in full, and KushCo options will be converted based on the exchange ratio.
- Greenlane will seek approval to increase shares available under its 2019 Equity Incentive Plan to 7.5% of the aggregate Class A and Class B shares outstanding after the merger and Class C conversion.
Conditions, outlook, risks, and unusual items
- Closing requires, among other conditions, KushCo stockholder approval; specified Greenlane stockholder approvals; repayment of certain KushCo indebtedness and release of related liens; Nasdaq approval; effectiveness of a Form S-4 registration statement; expiration of the Hart-Scott-Rodino waiting period; tax opinions; and satisfaction of customary representations, covenants, and material-adverse-effect conditions.
- The merger agreement may be terminated if the transaction is not completed by December 31, 2021, subject to one 30-day extension, or under other specified circumstances, including failed stockholder approvals, material breaches, government restraints, or a qualifying material adverse effect.
- Either party may pursue a superior acquisition proposal under specified fiduciary-out procedures. A termination fee equal to 4% of the terminating party’s equity value at signing may apply in specified circumstances.
- Jacoby & Co., controlled by Greenlane co-founders, held approximately 62% of Greenlane’s outstanding shares and agreed to vote on specified transaction-related matters. Its voting agreement excludes voting on adoption of the merger agreement and terminates upon specified events.
- KushCo directors Nicholas Kovacevich and Dallas Imbimbo held approximately 12% of KushCo’s outstanding shares and entered into voting agreements supporting the transaction.
- The transaction remains subject to regulatory, stockholder, financing-related, registration, and other closing risks. The filing states that representations and warranties in the merger agreement should not be relied upon as factual descriptions of current conditions.
Important facts for investors to verify
- Review the definitive Form S-4 and joint proxy statement/prospectus, including the final exchange ratio, pro forma ownership, dilution, and transaction adjustments.
- Verify whether all required Greenlane and KushCo stockholder approvals, Nasdaq approval, antitrust clearance, and lien releases are obtained.
- Review KushCo’s indebtedness and the required repayment terms, as well as the combined company’s pro forma debt and liquidity.
- Assess the effect of accelerated equity-award vesting and the proposed 7.5% equity-plan reserve on dilution and compensation expense.
- Confirm whether the merger closes by the contractual deadline and monitor termination rights, termination-fee exposure, and any competing acquisition proposals.